Literature DB >> 27926724

New anti-IL-23 drugs raise hopes for psoriasis plaque clearance.

Elie Dolgin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27926724     DOI： 10.1038/nbt1216-1218

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

1.  Suicidal thoughts end Amgen's blockbuster aspirations for psoriasis drug.

Authors:  Charlie Schmidt
Journal:  Nat Biotechnol       Date:  2015-09       Impact factor: 54.908

2.  IL-17-targeting biologics aim to become standard of care in psoriasis.

Authors:  Mark Ratner
Journal:  Nat Biotechnol       Date:  2015-01       Impact factor: 54.908
  2 in total
  5 in total

1.  Retinoic acid-induced autoantigen-specific type 1 regulatory T cells suppress autoimmunity.

Authors:  Mathilde Raverdeau; Maria Christofi; Anna Malara; Mieszko M Wilk; Alicja Misiak; Lucia Kuffova; Tian Yu; Aoife M McGinley; Shauna M Quinn; Chandirasegaran Massilamany; Jay Reddy; John V Forrester; Kingston Hg Mills
Journal:  EMBO Rep       Date:  2019-03-20       Impact factor: 8.807

2.  Go-ahead for first anti-IL-23 mAb to treat psoriasis.

Authors: 
Journal:  Nat Biotechnol       Date:  2017-09-11       Impact factor: 54.908

3.  Neutrophil Extracellular Traps Induce Human Th17 Cells: Effect of Psoriasis-Associated TRAF3IP2 Genotype.

Authors:  Sylviane Lambert; Caely A Hambro; Andrew Johnston; Philip E Stuart; Lam C Tsoi; Rajan P Nair; James T Elder
Journal:  J Invest Dermatol       Date:  2018-12-05       Impact factor: 8.551

4.  The risk of organ-based comorbidities in psoriasis: a systematic review and meta-analysis.

Authors:  Xuemei Tang; Ling Chen
Journal:  An Bras Dermatol       Date:  2022-07-15       Impact factor: 2.113

Review 5.  Psoriasis therapy by Chinese medicine and modern agents.

Authors:  Shikang Meng; Zibei Lin; Yan Wang; Zhenping Wang; Ping Li; Ying Zheng
Journal:  Chin Med       Date:  2018-03-23       Impact factor: 5.455
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.